Literature DB >> 21930467

Complications of transcatheter aortic valve implantation: avoidance and management.

David Hildick-Smith1, Simon Redwood, Michael Mullen, Martyn Thomas, Jan Kovac, Stephen Brecker, Uday Trivedi, Chris Young, Nevil Hutchinson, Phil Maccarthy, Bernard Prendergast, Mark De Belder, Mark Monaghan, Dan Blackman, Andreas Baumbach, Ganesh Manoharan, Neil Moat.   

Abstract

Transcatheter aortic valve implantation (TAVI) has taken the world of cardiovascular therapies by storm. The possibility of implanting aortic valves without recourse to sternotomy or cardiopulmonary bypass has been embraced by cardiologists, surgeons and patients alike as a revolution in management. First performed in 2002 by Alain Cribier, the technique has exploded into common use during the last three years, such that over 20,000 implants have now been undertaken worldwide. This article discusses complications of TAVI, their avoidance and management.

Entities:  

Mesh:

Year:  2011        PMID: 21930467     DOI: 10.4244/EIJV7I5A99

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  3 in total

1.  Surgical site infections following transcatheter apical aortic valve implantation: incidence and management.

Authors:  Richard Baillot; Éric Fréchette; Daniel Cloutier; Josep Rodès-Cabau; Daniel Doyle; Éric Charbonneau; Siamak Mohammadi; Éric Dumont
Journal:  J Cardiothorac Surg       Date:  2012-11-13       Impact factor: 1.637

2.  The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry.

Authors:  Panagiotis Tzamalis; Valentin Herzberger; Jens Bergmann; Alexander Wuerth; Peter Bramlage; Holger Schroefel; Claus Schmitt; Gerhard Schymik
Journal:  Cardiovasc Diabetol       Date:  2019-05-28       Impact factor: 9.951

3.  Micro-dislodgement during transcatheter aortic valve implantation with a contemporary self-expandable prosthesis.

Authors:  Katharina Hellhammer; Kerstin Piayda; Shazia Afzal; Verena Veulemans; Inga Hennig; Matthias Makosch; Amin Polzin; Malte Kelm; Tobias Zeus
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.